GlassScriptPhysician profile
Tatia M Call
NPI 1326718727
$381.05
in general payments reported to CMS, 2019-2025
16 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $78.53 · 2023: $77.42 · 2024: $71.23 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $268 · Education: $34.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $267.76 |
| Education | $34.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $48.93 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Dexcom, INC. | $44.98 | 2022-2023 | Dexcom G6 Transmitter |
| Insmed, INC. | $34.76 | 2025 | Brinsupri |
| Novo Nordisk INC | $26.89 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $24.07 | 2022 | |
| Servier Pharmaceuticals LLC | $23.99 | 2025 | |
| Abbvie INC. | $22.99 | 2024 | |
| Novartis Pharmaceuticals Corporation | $22.81 | 2025 | |
| Taiho Oncology, INC. | $21.41 | 2025 | |
| Incyte Corporation | $19.07 | 2025 | Monjuvi, Zynyz |
| Amgen INC. | $16.84 | 2024 | Evenity, Prolia |
| Aveo Pharmaceuticals, INC. | $15.88 | 2025 | |
| Glaxosmithkline, LLC. | $15.56 | 2023 | Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.73 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $14.50 | 2024 | Farxiga |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | $13.64 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tatia Call listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.